2Hosepud JD, Bennett LE, Keek BM, et al. Heart and lung transplantation: Seventeenth official report-2000 [ J ]. J Heart Lung Transplant, 2000,19:909 - 931.
3Bourge RC, Naftel DC Costanzo-Nordin MR, et al. For the transplant Cardiologists Research Database Group: Protrasnplantation risk factors for death after heart transplantation: a multi-institutional study[ J]. J Heart Lung Transplant, 1993,12:549 - 562.
4Chen JM, Levin HR, Michler RE, et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation : determination of optimal thresholds and quantification of the effect of reversibility on pefioperative mortality [ J ]. J Thorac Cardiaovasc Surg, 1997,114:627 - 634.
5Efikson KW, Constanzo Nordin MR, O' Sullivan EJ,et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation [ J ]. J Heart Transplant, 1990, 9:526 - 537.
6Stobierska-Dzierzek B, Awad H, Robert E, et al. The evolving management of acute right-side heart failure in cardiac transplant recipients [ J ]. KACC, 2001,38:923 - 931.
7Bhatia SJ, Krshenbaum JM, Shemin RJ,et al. Time eouse of resolution of pulmonary hypertension and fight ventricular remodeling after orthetopie cardiac transplantation [ J ]. Circulation, 1987,76:819 - 826.
8Fischer LG, Aken HV, Fanzca F,et al. Management of pulmonary hypertension: Physiological and pharmacological consideration for anesthesiologists [ J]. Anesth Analg, 2006,96 : 1603 - 1616.
9Heedt PM, Weiss CL. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertensuin[ J]. Snn Trorac Surg, 1990,49:463 - 465.
10Kwak YL, Lee CS,Part YH, et al. The effect of phynylephrine and norepinephfine in patients with chronic pulmonary hypertension[ J]. Anesthesia,2002,57 : 1 - 9.
